Why does CAAC focus heavily on neuroblastoma research?
Neuroblastoma, a cancer of the sympathetic nervous system, is one of the hardest cancers for children to beat. This cancer is generally diagnosed in infants and children under the age of 6. One in four of these children diagnosed with neuroblastoma with not survive the disease. The research findings in neuroblastoma therapies have also been helpful in addressing treatment options for children fighting other types of childhood cancers.